Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study
NCT01101555
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Arthritis, Rheumatoid
Interventions
DRUG:
subcutanious administration
OTHER:
Placebo
Sponsor
GlaxoSmithKline